Conquering Diseases

Study Of An Investigational Drug Combination For Multiple Myeloma


Seeking men and women whose multiple myeloma has returned or gotten worse despite treatment for a study comparing investigational drug combinations.


Participants in this study will receive one of three different drug combinations, the standard treatment drug combination, the investigational drug with one other drug (Tal-D), or the investigational drug with two other drugs (Tal-DP) every 28 days.

What we're hoping for

We are comparing whether one investigational drug combination is better than another

Additional Information Identifier: NCT05455320

 Principal Investigator

Muthalagu  Ramanathan, MD

UMass Memorial Health

 Study Contact

The Cancer  Research Office



UMass Chan University Campus

55 Lake Ave North 

Worcester,MA 01655